Infinera to Participate in Deutsche Bank Investor Conference
Sep 05, 2017 12:00 pm UTC| Business
SUNNYVALE, Calif., Sept. 05, 2017 -- Infinera Corporation (NASDAQ:INFN), a provider of Intelligent Transport Networks, announced that it will participate in the following webcasted investor conference: Deutsche Bank...
FuelCell Energy Announces 20 Megawatt Fuel Cell Project with Korea Southern Power Company
Sep 05, 2017 12:00 pm UTC| Business
DANBURY, Conn., Sept. 05, 2017 -- FuelCell Energy, Inc. (Nasdaq:FCEL), a global leader in delivering clean, innovative and affordable fuel cell solutions for the supply, recovery and storage of energy, today announced...
Proteon Therapeutics to Present at the Baird 2017 Global Healthcare Conference September 7, 2017
Sep 05, 2017 11:45 am UTC| Business
WALTHAM, Mass., Sept. 05, 2017 -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular diseases, today...
Tara French to Join Northfield Bank as Executive Vice President and Chief Administrative Officer
Sep 05, 2017 11:39 am UTC| Business
WOODBRIDGE, N.J., Sept. 05, 2017 -- Northfield Bank, wholly-owned subsidiary of Northfield Bancorp, Inc. (NASDAQ:NFBK) announced today that Tara French will join Northfield as Executive Vice President and Chief...
Sep 05, 2017 11:30 am UTC| Business
The preeminent data, content and analytics platform to the global institutional investment industry A subscription-based SaaS recurring revenue model that has delivered double-digit organic revenue growth Acquisition...
TG Therapeutics Announces Completion of Target Enrollment in the UNITY-CLL Phase 3 Trial
Sep 05, 2017 11:30 am UTC| Business
NEW YORK, Sept. 05, 2017 -- TG Therapeutics, Inc. (NASDAQ:TGTX) today announced that target enrollment for the UNITY-CLL Phase 3 trial has been achieved. The UNITY-CLL Phase 3 trial is a randomized study of TG-1101...
Mustang Bio to Present at the CAR-TCR Summit 2017
Sep 05, 2017 11:30 am UTC| Business
NEW YORK, Sept. 05, 2017 -- Mustang Bio, Inc. (“Mustang”) (NASDAQ:MBIO), a Fortress Biotech (NASDAQ:FBIO) Company focused on the development of novel immunotherapies based on proprietary chimeric antigen receptor...